about
mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.The reciprocal regulation of gamma-synuclein and IGF-I receptor expression creates a circuit that modulates IGF-I signaling.Matrix metalloproteinases in tumorigenesis: an evolving paradigm.Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response.AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.The anticancer flavonoid chrysin induces the unfolded protein response in hepatoma cells.ACER3 supports development of acute myeloid leukemia.Cell surface GRP78 facilitates hepatoma cells proliferation and migration by activating IGF-IR.ADCY7 supports development of acute myeloid leukemia.FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis.Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagationCEP55 Promotes Cell Motility via JAK2⁻STAT3⁻MMPs Cascade in Hepatocellular CarcinomaSPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signalingElevated SH3BP5 Correlates with Poor Outcome and Contributes to the Growth of Acute Myeloid Leukemia CellsAlkaline ceramidase 3 promotes growth of hepatocellular carcinoma cells via regulating S1P/S1PR2/PI3K/AKT signaling
P50
Q28270006-CEFB7700-906D-47BC-959D-CEE1CCDE9A22Q33892907-D79F007D-E520-419B-9334-2E2149A205B9Q34155259-1A8C832B-58C1-45F4-A8A9-13A339D854D0Q34199345-B9F35337-3E3F-4784-B333-EDC8F3B381CFQ35893417-6282C38F-66BE-49F4-8A2A-2AEE81D15805Q37086032-8D0406AB-6F47-43B4-B9F8-1FBCB37DC9D2Q37294853-A8C86F54-D9D7-41CC-971E-F46D5F1C1D44Q38754934-83CBA228-C8BF-4399-AA6C-FA900ECCC8F2Q38847254-5362D1E1-A44D-47B2-9CDF-9512773DFA55Q38848436-13C1CD4B-591D-4E16-A2F2-13BBEDF82D2CQ38929258-3DE28705-0CFD-40BA-BBA2-B643F0B6DED0Q47144046-43DD7053-A222-46E9-8E1B-BFDE11114B40Q57490701-8D9308F4-1F40-43AD-A460-79B1A6301C71Q58795154-DA1AA6C0-2E01-461B-8DFC-F643C382248CQ88532167-315CDE92-7BD4-4662-9D88-051C4321B93DQ90226091-E2693305-C89E-4E89-9582-B0D27FCAD72CQ90877309-49B353CB-1D82-431F-A74C-2C5E013496A2
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yancun Yin
@en
Yancun Yin
@nl
type
label
Yancun Yin
@en
Yancun Yin
@nl
prefLabel
Yancun Yin
@en
Yancun Yin
@nl
P31
P496
0000-0003-2755-9595